>>Signaling Pathways>> Neuroscience>> Monoamine Oxidase>>Isocarboxazid

Isocarboxazid (Synonyms: NSC 169893, Ro 5-0831)

Catalog No.GC31104

Isocarboxazid는 in vitro에서 쥐의 뇌 모노아민 산화효소에 대한 IC50이 4.8μM인 모노아민 산화효소의 비선택적이고 비가역적인 억제제입니다.

Products are for research use only. Not for human use. We do not sell to patients.

Isocarboxazid Chemical Structure

Cas No.: 59-63-2

Size 가격 재고 수량
5mg
US$82.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Isocarboxazid is a non-selective and irreversible inhibitor of monoamine oxidase, with an IC50 of 4.8 μM for rat brain monoamine oxidase in vitro[1].

Isocarboxazid (1, 3 mg/kg, i.p., 60 min) pretreatment in mice shows the significant increased number of head twitches at 15 and 30 min after 5-HTP[2].Isocarboxazid (1, 3 mg/kg, i.p., 60 min) treatment in mice together with 5-HTP administration causes 43% 5-HT concentration increased and 22% of 5-HIAA decreased compared to brain concentrations in mice given 5-HTP alone[2].|| Animal Model:|Twelve male mice of dd strain (20-25 g)[2]|Dosage:|0, 0.3,1, 3 mg/kg|Administration:|Intraperitoneally 60 min before intravenous injection of 5-HTP|Result:|The number of head twitches at 15 and 30 min after 5-HTP was increased.43% 5-HT concentration increased and 22% of 5-HIAA decreased.

[1]. MAXWELL DR, et al. Relative activity of some inhibitors of mono-amine oxidase in potentiating the action of tryptamine in vitro and in vivo. Br J Pharmacol Chemother. 1961 Dec;17:310-20.

리뷰

Review for Isocarboxazid

Average Rating: 5 ★★★★★ (Based on Reviews and 19 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Isocarboxazid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.